You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

Shilpa Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for SHILPA, and when can generic versions of SHILPA drugs launch?

SHILPA has fourteen approved drugs.

There are five US patents protecting SHILPA drugs. There are two tentative approvals on SHILPA drugs.

There are fifty-four patent family members on SHILPA drugs in twenty-six countries and fifty supplementary protection certificates in sixteen countries.

Summary for Shilpa
International Patents:54
US Patents:5
Tradenames:12
Ingredients:12
NDAs:14
Patent Litigation for Shilpa: See patent lawsuits for Shilpa

Drugs and US Patents for Shilpa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shilpa DOCETAXEL docetaxel INJECTABLE;INJECTION 210327-002 May 16, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up
Shilpa IMATINIB MESYLATE imatinib mesylate TABLET;ORAL 208302-001 Jan 17, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up
Shilpa DOCETAXEL docetaxel INJECTABLE;INJECTION 210327-003 May 16, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Shilpa Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0253738 C960002 Netherlands ⤷  Sign Up PRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127
0564409 C00564409/01 Switzerland ⤷  Sign Up PRODUCT NAME: IMATINIB; REGISTRATION NO/DATE: IKS 55807 20010621
0432677 7/2005 Austria ⤷  Sign Up PRODUCT NAME: PEMETREXED UND DESSEN PHARMAZEUTISCH ANNAHMBAREN SALZE; REGISTRATION NO/DATE: EU/1/04/290/001 20040920
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.